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The pathogenesis of human infl  ammatory bowel 
disease (IBD) is thought to involve a dysregu-
lated immune response to common luminal 
bacterial antigens (1). An intact mucosal barrier 
and regulatory mechanisms normally prevent 
the gut immune and infl  ammatory response, 
which protects the host from pathogenic agents, 
from proceeding to tissue injury and auto-
immunity. Activated T lymphocytes have been 
shown to play an important role in chronic 
infl  ammation of the intestine in both human IBD 
and in experimental mouse models of colitis.
In a mouse adoptive transfer model of IBD, 
transfer of naive CD4+ cells into a lymphocyte-
depleted mouse induces mucosal infl  ammation 
of the colon (2). However, this intestinal in-
fl  ammation is prevented when CD4+ regula-
tory T cells are concomitantly transferred with 
naive CD4+ T cells (2), demonstrating a potent 
suppressive role for regulatory T cells in intes-
tinal infl  ammation in vivo. Regulatory T (T reg) 
cells are a subset of CD4+ T cells capable of 
  inhibiting autoimmune responses. Naturally oc-
curring T reg cells arise spontaneously in vivo, 
express a unique transcription factor, Foxp3, and 
control responses to tissue-specifi  c autoantigens 
that are presented to the immune system via 
mucosal surfaces (3).   Immune tolerance is an im-
portant mechanism to prevent an excessive ad-
verse reaction to the diverse luminal foreign 
antigens and bacterial pathogens in the intestine, 
and is mediated in part by subsets of CD4+ T cells 
(T reg cells), which are characterized by the 
secretion of TGF-β and IL-10. Important ques-
tions remain unanswered regarding where this 
inhibition takes place and the molecular mecha-
nism of T reg cell traffi   cking in vivo.
Chemokines are a superfamily of chemo-
tactic cytokines that control leukocyte migration 
via G protein–coupled receptors expressed on 
target cells (4). The chemokine receptors CCR4 
and CCR8 were found to be functionally ex-
pressed on human peripheral blood CD4+CD25+ 
T reg cells (5). In patients with ovarian car-
cinoma, the host response to the tumor was 
shown to be inhibited by Foxp3+CCR4+ T reg 
cells that were recruited into the tumor as a 
result of the tumor-derived CCR4 ligands, 
CCL17 and CCL22 (6). In a mouse cardiac 
allotransplantation model, CCR4 and CCL22 
were up-regulated in tolerized allografts, and 
tolerance induction could not be achieved in 
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Infl  ammatory bowel disease (IBD) is an idiopathic infl  ammatory disease of the intestine. 
CD4+ T lymphocytes play an important role in both initiating and regulating intestinal 
infl  ammatory immune responses. CD4+CD25+CD45RBlow regulatory T (T reg) cells are 
capable of preventing the development of colitis in a mouse model of IBD. The precise 
mechanism of T reg cell–mediated prevention of colitis in this model is unclear, and the 
role of chemokine receptors in the traffi  cking and function of T reg cells in this model has 
not been determined. We examined the role of the chemokine receptor CCR4 in in vivo 
traffi  cking and suppressive function of T reg cells in a mouse adoptive transfer model of 
IBD. CCR4-defi  cient T reg cells failed to accumulate in the mesenteric lymph nodes (MLNs) 
at early time points (2–5 d) after adoptive transfer, resulting in a failure to suppress the 
generation of pathogenic T cells and the development of colitis. Moreover, although CCR4-
defi  cent T cells had equivalent in vitro suppressive activity and accumulated in MLNs at 
later time points (42–56 d), they were unable to suppress colitis. Our study demonstrates 
that CCR4 plays an important role in T reg cell traffi  cking in LNs and that this is critical 
for T reg cell suppressive function in vivo.
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CCR4-defi  cient  (CCR4−/−) recipients, indicating an im-
portant role of CCR4 in the generation and/or recruitment 
of Foxp3+ T reg cells into cardiac allografts (7). Furthermore, 
CCR5 was recently shown to play a role in the migration of 
T reg cells into dermal sites of chronic cutaneous Leishmania 
major infection (8), whereas another recent study found that 
CCR7 was required for T reg cell function in the LN in a 
mouse model of IBD (9).
In the current study, we examined the role of CCR4 in 
T reg cell function and traffi   cking in the mouse adoptive 
transfer model of IBD. CCR4−/− T reg cells demonstrated 
delayed accumulation in mesenteric LNs (MLNs) at early 
time points after adoptive transfer and ineff  ective accumula-
tion within the MLN at later time points. This impaired 
the ability of T reg cells to suppress the generation of auto-
immune pathogenic eff  ector T cells and the development of 
colitis in recipient mice.
RESULTS AND D  I  S  C  U  S  S  I  O  N 
Chemokine receptor expression in T reg cells
To determine the expression of chemokine receptors in wild 
type (WT) T reg cells, we isolated CD4+CD25+CD45RBlow 
T reg cells and naive CD4+CD25−CD45RBhigh T cells 
from WT C57BL/6 mice and performed quantitative PCR 
(QPCR) analysis. QPCR was used because of the limited 
availability of mAbs to mouse chemokine receptors for FACS 
analysis. As expected, in naive T cells, CCR7 and CXCR4 
were the two chemokine receptors highly expressed, which 
is consistent with their naive phenotype (Fig. 1 A, shaded 
bar). In T reg cells, CCR7 and CXCR4 were expressed, but 
at much lower levels than in naive T cells. Interestingly, there 
were several additional chemokine receptors expressed in 
T reg cells, including: CCR1, CCR3, CCR4, CCR6, CCR8, 
CCR10, CCR11, CXCR3, CX3CR1, and the leukotriene 
B4 receptor BLT1 (Fig. 1 A, open bar). This diff  erential 
chemokine receptor expression between T reg cells and naive 
T cells implies distinct traffi   cking and functional characteristics 
between theses two T cell populations.
In the mouse model of IBD using adoptive transfer of 
pathogenic CD4+CD45RBhigh T cells, 8 wk after adoptive 
transfer when clinical disease is evident, mRNA levels for 
CXCR3, CCR4, CCR5, and CCR6 have been found to be 
increased in the infl  amed colon, suggesting that these chemo-
kine receptors may play a role in CD4+CD45RBhigh T cell 
traffi   cking and function (10). We sought to determine the 
expression of chemokine receptors on T reg cells capable of 
inhibiting the development of infl  ammatory colitis. To do so, 
8 wk after cotransfer with naive CD4+CD25−CD45RBhigh 
T cells into T and B cell–defi  cient Rag-2−/− recipient mice, 
T reg cells were recovered from the spleen, lamina propria of 
the colon, and peripheral LNs and MLNs of recipient mice by 
FACS cell sorting, taking advantage of the Thy-1.1 (CD90.1) 
and Thy-1.2 (CD90.2) congenic markers. Naive pathogenic 
T cells were from the Thy-1.1 congenic strain, and T reg cells 
were from the congenic Thy-1.2 strain. Expression of chemokine 
receptors in recovered T reg cells varied markedly, depending 
on the anatomical sites, and the levels were much higher com-
pared with T reg cells before adoptive transfer (Fig. 1 B). 
CCR4, CCR5, CCR6, CCR8, CCR9, CXCR3, and BLT1 
were highly up-regulated in T reg cells recovered from MLNs. 
Of note, these T reg cells expressed TGF-β1, but not IL-10 
(Fig. 1 B). These results suggest that the microenvironment in 
Figure 1.  Expression of chemokine receptors in T reg cells. 
(A) QPCR analysis of chemokine receptor expression in freshly isolated WT 
CD4+CD25+CD45RBlo T reg cells (open bar) and CD4+CD25−CD45RBhi 
naive T cells (shaded bar). (B) Expression of chemokine receptors in WT 
T reg cells recovered from the spleen (open bar), lamina propria of the 
colon (light gray bar), peripheral LN (fi  lled bar), and MLN (dark gray bar) 8 wk 
after cotransfer with pathogenic T cells. (C) Expression of chemokine 
receptors in virally transduced naive T cells expressing Foxp3 (shaded bar) 
or control MIGR vector (open bar). *, P < 0.001, as determined by a Student’s 
t test. Error bars indicate the SD of triplicate measurements. In A and B, 
T reg or naive T cells were isolated from fi  ve different mice, and the data 
are representative of three similar independent experiments.JEM VOL. 204, June 11, 2007  1329
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the lymphoid organ draining the site of infl  ammation plays an 
important role in regulating chemokine receptor expression 
in T reg cells, hence regulating the traffi   cking and function of 
these cells in vivo.
Retroviral gene transfer of Foxp3 has been shown to con-
vert naive T cells into functional T reg cells (11). We intro-
duced Foxp3 into naive CD4+CD25−CD45RBhigh T cells by 
retroviral transduction, and analyzed expression of chemokine 
receptors in these virally transduced Foxp3+ T cells. Com-
pared with T cells transduced with vector alone (controls), 
expression of CCR4, CCR7, and CCR8 was markedly up-
regulated in cells transduced with Foxp3+ (Fig. 1 C, shaded 
bars). Interestingly, these chemokine receptors have all previ-
ously been implicated in T reg cell traffi   cking and function, 
including CCR7, which was shown to control the migration 
of CD4+CD25+CD69− human T reg cells to tonsilar germi-
nal centers (12). Collectively, these results indicate that a sub-
set of chemokine receptors expressed in T reg cells likely play 
important roles in T reg cell traffi   cking and function.
CCR4−/− T reg cells fail to protect development of colitis 
in vivo
To determine the importance of CCR4 in T reg cell in vivo 
function, we performed the mouse model of IBD by adop-
tively transferring WT naive T cells with or without cotrans-
ferring WT or CCR4−/− T reg cells into Rag-2−/− recipient 
mice. As expected, recipient mice that received WT naive 
CD4+CD25−CD45RBhigh T cells (pathogenic) alone de-
veloped severe colitis 8 wk after cell transfer, with marked 
edema and thickening of the colon and loss of normal, pellet-
shaped stools (Fig. 2 A, fi  rst panel, top). There was also a 
marked mononuclear cellular infi  ltrate and an alteration of 
normal colonic mucosal architecture (Fig. 2 A, fi  rst panel, 
bottom). Rag-2−/− mice that received cotransfer of WT 
CD4+CD25+CD45RBlow T reg cells and WT naive T cells 
were protected from developing colitis with a normal trans-
parent appearance of the colon, normal pellet-shaped stools, 
and normal mucosal structure (Fig. 2 A, second panel). In 
marked contrast, CCR4−/− T reg cells failed to prevent the 
development of colitis after being cotransferred with WT 
naive T cells, and the severity of colitis was comparable to 
that in mice that received naive T cell alone (Fig. 2 A, third 
panel). We also examined the eff  ects of two other chemokine 
receptors expressed in T reg cells, CCR2 and CCR5, on T reg 
function in the model. To do so, we coinjected Rag-2−/− 
mice with CCR2−/− T reg cells and WT naive T cells and 
CCR5−/− T reg and WT naive T cells. We found that both 
groups of recipient mice were protected from developing 
colitis (Fig. 2 A, fourth and fi  fth panels), suggesting that in 
contrast to CCR4, CCR2 and CCR5 are not required for 
T reg cell function in this model. To quantify the severity 
of colitis, we compiled the disease activity index (DAI) and 
Figure 2.  Development of colitis after adoptive cell transfer. 
(A, top) Gross appearance of colon in representative Rag-2−/− recipient 
mice 8 wk after cell transfer. Arrows indicate the distal cecum (a), the 
proximal cecum (b), the terminal ileum (c), and the colon (d). (bottom) 
Histological appearance of colon in representative mice. Bar, 250 μm. 
(B) 8 wk after cell transfer, DAI was compiled from individual mice based 
on wasting, stool consistency, and gross appearance of the colon. Higher 
number indicates more severe colitis. (C) Histological colitis score. Sections 
of colon from individual mice were imbedded in formalin and stained with 
hematoxylin and eosin. The severity of colitis was scored by our partici-
pating pathologist, who was blinded to each experiment. Number of mice/
group indicated on fi  gure (n) from three independent experiments.1330  CCR4-DEPENDENT T REG CELL FUNCTION IN COLITIS | Yuan et al. 
histological colitis score from individual recipient Rag-2−/− 
mice 8 wk after cell transfer. The DAI was compiled as previ-
ously described (13) based on the general appearance of the 
recipient mice (wasting), stool consistency, and the gross ap-
pearance of the colon, with higher scores representing more 
severe colitis. The histological colitis score was determined 
from hematoxylin and eosin–stained colon sections scored for 
the presence of crypt abscesses (0–1), the degree of mucosa 
thickness (0–3), and the degree of infl  ammatory infi  ltrate (0–3). 
The maximum score of the histological index was 7.
The mean DAI in mice that received WT naive patho-
genic T cells alone was 6.25 (n = 14), whereas in mice that 
received cotransfer of WT T reg cells and WT naive patho-
genic T cells the mean DAI was only 2.03 (n = 6; P < 0.001; 
Fig. 2 B). In contrast, mice that received cotransfer of 
CCR4−/− T reg cells and WT naive T cells, the mean DAI 
was 7.43 (n = 5), which was signifi  cantly higher than mice 
that received cotransfer of WT T reg cells and naive patho-
genic T cells (2.03; P < 0.001). The mean DAI in mice that 
received cotransfer of CCR2−/− T reg cells and WT naive 
T cells was 0.1 (n = 5) and mice that received cotransfer of 
CCR5−/− T reg cells and WT naive T cells was 1.04 (n = 8; 
Fig. 2 B). Furthermore, transfer of CCR4−/− naive patho-
genic T cells induced colitis similar to WT naive T cells, 
demonstrating that the eff  ect of CCR4 was specifi  c for T reg 
cell function and not T eff  ector cell function in this model 
(unpublished data).
The mean histologic colitis score in mice that received 
WT naive T cells alone was 5 (n = 14), whereas the mean 
colitis score in mice that received cotransfer of WT T reg 
cells and naive T cells was 0.67 (n = 6; P < 0.001; Fig. 2 C). 
In mice that received cotransfer of CCR4−/− T reg cells 
and WT naive T cells, the mean colitis score was 5.3 (n = 5), 
which is virtually indistinguishable from that in mice that 
received naive T cells alone (mean colitis score of 5.0; P = 0.67, 
not signifi  cant; Fig. 2 C). In contrast, the mean colitis score 
in mice that received cotransfer of CCR2−/− T reg cells and 
WT naive T cells was 1.0 (n = 5), and the mean colitis score 
in mice that received cotransfer of CCR5−/− T reg cells and 
WT naive T cells was 1.5 (n = 8), which were not sta  tistically 
signifi  cant from that in mice that received WT T reg cells and 
WT naive T cells (mean colitis score of 0.67; n = 5; P = 0.56). 
These results indicate that the chemokine receptor CCR4 
is critical for T reg cell function in vivo.
To further explore the mechanism of CCR4-dependent 
T reg cell in vivo function, we compared the expression of 
T reg cell markers and suppressive function of CCR4−/− 
and WT T reg cells. We found no signifi  cant diff  erence in 
the expression of Foxp3, CTLA4, integrin αE, GITR, and 
the cytokines IL-10 and TGF-β between the two groups of 
T reg cells (Fig. 3 A). We also found no diff  erence in the 
ability of CCR4−/− and WT T reg cells to inhibit the pro-
liferation of naive T cells in vitro (Fig. 3 B). These results in-
dicate that diff  erence in the suppressive function between 
CCR4−/− and WT T reg cells is likely a direct result of de-
fi  cient CCR4 expression.
CCR4−/− T reg cells have an altered pattern 
of in vivo traffi  cking
We hypothesized that the specifi  c subset of chemokine re-
ceptors expressed by T reg cells will aff  ect their function in 
vivo by infl  uencing their homing properties. In the afore-
mentioned in vitro T reg cell assay, cells are incubated in 
wells with a small area, and thus migration is likely less im-
portant for localization of T reg with DC and pathogenic 
T cells than in lymphoid tissues. Therefore, we determined 
the traffi   cking patterns of CCR4−/− T reg cells and WT 
T reg cells at diff  erent time points after adoptive transfer into 
Rag-2−/− mice. We analyzed the distribution of CCR4−/− 
and WT T reg cells after cotransfer with WT naive T cells 
into Rag-2−/− recipient mice. CCR4−/− T reg cells and WT 
T reg cells were recovered from diff  erent lymphoid organs at 
diff  erent time points after adoptive transfer into Rag-2−/− 
mice, and the percentage and absolute numbers of T reg cells 
in each organ were determined by FACS analysis. The naive 
pathogenic T cells were from the Thy-1.1 strain, and the 
CCR4−/− T reg cells and WT T reg cells were from the 
congenic Thy-1.2 strain. The percentage of CCR4−/− T reg 
cells of total CD4+ cells and the absolute cell numbers of 
CCR4−/− T reg cells were signifi  cantly less than that of the 
WT T reg cells in the MLN 2 and 5 d after cell transfer 
Figure 3.  In vitro acitivity of CCR4−/− T reg cells. (A) Expression of 
T reg cell–related markers and cytokines by QPCR in CCR4−/− T reg cells 
(shaded bar) and WT T reg cells (open bar) (n = 3 mice/group). (B) Inhibi-
tion of naive T cell proliferation by CCR4−/− T reg cells (closed square) and 
WT T reg cells (open square). Closed and open triangles represent CCR4−/− 
T cells alone and WT T reg cells alone, respectively.JEM VOL. 204, June 11, 2007  1331
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(Fig. 4, A and B). This most likely represents impaired hom-
ing and/or retention of CCR4−/− T reg cells in the MLN, as 
adoptively transferred T reg cells do not begin to divide until 
1 wk after transfer (14). However, from day 42 after cell 
transfer onward, the percentage and absolute number of 
CCR4−/− T reg cells in the MLN were greater than that of 
WT T reg cells (Fig. 4, C and D). At these later time points, 
CCR4−/− T reg cells are likely recruited and/or retained in 
the MLN by infl  ammation-induced non-CCR4 chemo-
kines, where their expansion is driven by the profound in-
fl  ammation that develops in these mice 6 wk after adoptive 
transfer of CCR4−/− T reg cells, in contrast to the absence of 
disease in mice that received WT T reg cells. There were no 
signifi  cant diff  erence in the percentage and cell numbers 
between CCR4−/− T reg cells and WT T reg cells in the colon, 
peripheral nondraining LNs, and spleen at all time points 
examined (unpublished data).
The decrease in CCR4−/− T reg accumulation resulted 
in an increase in the percentage and numbers of WT patho-
genic T cells generated in the MLN at all time points studied 
compared with mice that received WT T reg cells (Fig. 4, 
E and F). These data suggest that inhibition of T cell priming 
in the draining LN is critical for T reg cell–mediated suppres-
sion of colitis development, and implies that the MLN is 
likely the anatomical site where WT T reg cells exert their 
suppressive eff  ect upon pathogenic T cells. Evidence exists to 
support the notion that the ability of T reg cells to home to 
LN is critical for their in vivo function. Although CD62Lhigh 
and CD62Llow T reg cells have similar in vitro suppressive 
capacity, CD62LhighCD4+CD25+ T reg cells that home to 
LNs have a greater in vivo suppressive activity than CD62Llow 
T reg cells that home to the periphery in preventing autoim-
munity and graft-versus-host disease (15–17). This concept 
was further supported by the observation that T reg cells de-
fi  cient in integrin β7 expression were unable to traffi   c to the 
colon after adoptive cell transfer in the mouse adoptive transfer 
model of IBD, but still had similar in vivo suppressive eff  ect, 
as WT T reg cells in preventing development of colitis (18). 
Because migration of T reg cells into the MLN is not medi-
ated by the integrin β7, control of the induction phase of in-
fl  ammation within the MLN was not impaired. Furthermore, 
in an IBD model similar to the one used here, CCR7 func-
tion was recently shown to be required on T reg cells for 
their ability to suppress colitis; this was also correlated with 
the ability of T reg cells to enter LNs (9). Collectively, these 
studies and ours support a critical role for T reg cells in the 
MLN to suppress colitis in this model.
Intravital microscopy has shown that T reg cells directly 
interact with antigen-bearing DCs and can down-modulate 
CD4+ T cell immune responses by inhibiting stable interac-
tions between reactive CD4+ T cells and DCs during prim-
ing in LNs (19, 20). Both reactive CD4+ T cells and T reg 
cells migrate adjacent to CD11c+ DCs at the T cell–B cell 
boundary of the pancreatic LNs in nonobese diabetic mice 
(19). In the model of IBD used in our study, T reg cells have 
been found adjacent to clusters of CD11c+ cells and patho-
genic T cells in the MLN (21). At early time points (2–5 d) 
after cell transfer, few CCR4-defi  cient T reg cells accumu-
late in the MLN. Reduced numbers of CCR4- defi  cient 
T reg cells compared with WT T reg cells in the MLN may 
result from their decreased entry into and/or decreased re-
tention within the LN, which is caused by an impaired ability 
to migrate within the LN and make eff  ective cell contacts. In 
support of the notion that CCR4 is important for T reg cell 
homing within the MLN, we found that the CCR4 ligands 
CCL17 and CCL22 were highly expressed in the MLNs of 
both Rag-2−/− mice and WT mice, as compared with the 
colon (Fig. 5, A and B). They were also highly expressed in 
the MLN after adoptive transfer of WT naive T cells and WT 
T reg cells during the entire course of the model (Fig. 5 C), 
suggesting that this chemokine sytem can regulate T reg cell 
function throughout the model. Previous studies have 
demonstrated that CCL22 is expressed by maturing DCs that 
Figure 4.  Accumulation of WT and CCR4−/− T reg and pathogenic 
T cells in the MLN. (A and C) Percentage of T reg cells in total CD4+ 
cells in the MLN after adoptive cell transfer with pathogenic T cells. 
(B and D) Absolute numbers of T reg cells in the MLN after adoptive cell 
transfer with pathogenic T cells. (E) Percentage and (F) absolute numbers 
of WT pathogenic T cells in the MLN after adoptive cell transfer with WT 
and CCR4−/− T reg cells. The bars represent the means of the indicated 
number of mice from two independent experiments.1332  CCR4-DEPENDENT T REG CELL FUNCTION IN COLITIS | Yuan et al. 
have migrated from the periphery and entered the T zone of 
LNs (22) and can mediate T cell–DC cluster formation, 
which is mediated by CCR4 expressed on T cells and CCL22 
produced by DCs (23). Thus, WT T reg cells may migrate 
toward DC-produced CCL22, form conjugates with the 
antigen-presenting cell, and be retained within the LN. In con-
trast, CCR4-defi  cient T reg cells may fail to migrate toward 
DCs and/or form conjugates with antigen-presenting cells, 
and instead continue their transit through the LN and exit 
into the lymph. At later time points (42–56 d), we fi  nd that 
T reg cells greatly accumulate in the MLN, perhaps respond-
ing to the production of infl  ammatory chemokines within 
the LN, as we found that T reg cells recovered from the 
MLN 8 wk after adoptive transfer expressed several additional 
chemokine receptors, including CCR5, CCR6, CCR8, 
CCR9, and CXCR3. However, CCR4-defi  cient T reg cells 
are still unable to control disease, perhaps because of an in-
ability to make eff  ective contacts with DCs in vivo. This may 
explain our observation that even though CCR4−/− T reg 
cells expanded in the MLN at late time points after transfer 
and were equally eff  ective at inhibiting T cell proliferation as 
WT T reg cells in vitro, they were unable to eff  ectively in-
hibit colitis at these later time points. This interpretation is 
supported by the observation that WT T reg cells are able to 
suppress ongoing disease in the model, even when added af-
ter colitis has already developed (21). Thus, the absence of 
CCR4 on T reg cells impairs their early accumulation within 
the MLN and likely also impairs their migratory behavior 
and/or positioning once in the LNs, resulting in their func-
tional impairment.
In summary, using the mouse adoptive transfer model 
of IBD, we demonstrated that CCR4 plays an important 
role in T reg cell traffi   cking and function in vivo. Failure of 
CCR4−/− T reg cells to prevent the development of colitis 
after cotransfer with pathogenic T cells was the result of an 
inability of CCR4−/− T reg cells to control the generation 
of pathogenic T cells resulting from impaired traffi   cking of 
CCR4−/− T reg cells in the draining MLNs. Our results pro-
vide direct evidence of an important role for CCR4 in T reg 
cell traffi   cking and function within the MLNs in vivo in a 
mouse model of IBD, with implications for human IBD.
MATERIALS AND METHODS
Mice. WT C57BL/6 mice (Thy-1.2, CD90.2), WT congenic Thy-1.1 mice 
(CD90.1), and CCR4−/− (24), CCR2−/−, and CCR5−/− mice on C57BL/6 
background were obtained from The Jackson Laboratory. Rag-2−/− mice 
(C57BL/6 genetic background) were purchased from Taconic. All mice 
were kept in the specifi  c pathogen-free barrier room at our animal facility. 
Donor mice (C57BL/6, Thy-1.1, and CCR4−/− mice) were used at 6–8 wk 
of age, and recipient Rag-2−/− mice were used at 8–10 wk of age. All mice 
were age and gender matched for every experiment. The experimental 
protocol was approved by the Subcommittee of Research Animal Care of 
Massachusetts General Hospital according to Institutional Animal Care and 
Use Committee guidelines before the start of the study.
mAbs. Anti–mouse CD90.2-PE (Thy-1.2; clone 30-H12), anti–mouse 
CD90.1-FITC (Thy-1.1; clone OX-7), anti–mouse CD45RB-FITC (clone 
16A), anti–mouse CD25-PE (clone PC61), and anti–mouse CD3-APC 
(clone 145-2C11) were purchased from PharMingen. Anti–mouse CD4-Cy5.5 
(clone RM4-5) was purchased from Caltag.
Cell isolation. Naive CD4+CD25−CD45RBhi T cells and CD4+CD25+
CD45RBlow T reg cells were isolated from the LNs and spleen of donor 
mice by FACS cell sorting. Single-cell suspension was stained with a 
cocktail of directly conjugated mAbs, including anti–CD45RB-FITC, 
anti–CD25-PE, anti–CD3-APC, and anti–CD4-Cy5.5. The naive T cells 
and T reg cells were isolated by cell sorting using a MoFlo Cell Sorter 
(DakoCytomation).
Mouse model of experimental colitis. Immediately after cell sorting, naive 
T cells (4 × 105) and T reg cells (105) in 300 μl of cold Hanks’ medium con-
taining 2% FCS (Sigma-Aldrich) and 10 mM Hepes (Life Technologies) 
Figure 5.  Chemokine expression in MLN and colon. Levels of che-
mokines in the MLN (closed bars) and the colon (open bars) of the naive 
Rag-2−/− mice (A) or WT C57BL/6 mice (B). The bars represent the means 
of n = 6 mice from two independent experiments. (C) Levels of chemo-
kines in the MLN at the indicated time points after adoptive transfer of 
WT naive T cells and WT T reg cells into Rag-2−/− mice.JEM VOL. 204, June 11, 2007  1333
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were injected into recipient Rag-2−/− mice through the tail veins. In mice that 
received naive T cell alone, 4 × 105 naive T cells were injected. Recipient mice 
were kept in the specifi  c pathogen–free barrier room for 8–10 wk after cell 
transfer, with close monitoring for weight loss, diarrhea, and general wellbeing.
Assessment of colitis. Recipient mice were weighed weekly to follow 
colitis-associated wasting, and they were killed 8–10 wk after cell transfer. 
The clinical DAI was compiled as described by de Jong et al. (13), with 
higher scores representing more severe colitis. Histological colitis scores 
were obtained on sections of colons stained with hematoxylin and eosin and 
reviewed by our participating pathologist, Dr. A. Bhan, who was blinded to 
each experiment. The sections are scored for the presence of crypt abscesses 
(0–1), the degree of thickness (0–3), and the degree of infl  ammatory infi  l-
trate (0–3). The maximum score of histological index is 7.
Isolation of colonic lamina propria lymphocytes from the recipient 
mice. Isolation of lamina propria lymphocytes was performed according 
to published protocols (25), with modifi  cations. In brief, the entire colon 
(excluding the cecum) was removed from the animals and opened longitudi-
nally. 1–2-mm pieces were prepared with surgical scissors and incubated in 
RPMI containing 70 μg/ml Liberase Blendzyme 3 (Roche), 3 μg/ml 
DNase I (Sigma-Aldrich), and 1 mM DTT (Sigma-Aldrich) at 37°C for 90 min 
with constant shaking (200 rpm). The cell suspension was fi  ltered through a 
70-μM fi  lter (Falcon). Enterocyte contamination was removed by passing 
cell suspension through a glass-wool column. The fl  ow-through faction was 
collected, and it contained a mixture of lamina propria lymphocytes and 
intraepithelial lymphocytes.
Proliferation assay. Naive CD4+CD25−CD45RBhi T cells were isolated 
from the spleen and LNs of C57BL/6 mice by FACS sorting, and cultured 
at 5 × 104 cells/well in triplicate in the presence of irradiated APC and 
5 μg/ml soluble anti-CD3, in a 96-well fl  at-bottom tissue culture plate 
(Falcon). T reg cells were added to each well in varying numbers, with the 
ratio to naive T cells at 1:8, 1:4, 1:2, and 1:1. After culture for 72 h, 0.5 μCi 
of tritiated thymidine (NEN) were added to each well for the last 18 h.
QPCR. Total RNA was purifi  ed using the RNeasy kit (QIAGEN). After 
DNase I (Invitrogen) treatment, 2 μg of total RNA was used from reverse 
transcription reaction (Applied Biosystems). Primers used to examine the 
expression of chemokine receptors were designed using Primer Express soft-
ware 1.0 (PE Biosystems). All oligonucleotide primers were synthesized by 
Invitrogen. The QPCR reactions were perfomed in optical 96-well strips 
with optical caps (Stratagene) using the MX4000 Multiplex QPCR system 
(Stratagene). Quantity values generated for gene expression were obtained 
by comparison of the fl  uorescence generated by each sample with standard 
curves of known quantities and were divided by the quantity of total RNA 
present in each reaction.
Retroviral transduction of Foxp3 in naive T cells. Plasmid DNA con-
taining MigR1 vector and MigR1-Foxp3 were provided by A. Rudensky 
(University of Washington, Seattle, WA). Both MigR1-Foxp3 and MigR1 
plasmids were transfected into the packaging cell line, Plat E, using Fu-
gene (Roche). Naive CD4+CD25−CD45RBhi T cells were isolated from 
C57BL/6 mice and were transduced with Foxp3 or MigR1 vector-containing 
viral supernatant supplemented with 8 μg/ml polybrene, followed by cen-
trifugation for 90 min at 2,000 rpm and 72 h of incubation at 37°C, as previ-
ously described (26, 27). Foxp3-transduced cells were isolated by cell sorting 
for GFP expression.
Statistical analysis. Student’s t test (unpaired, two-tailed) was used to cal-
culate signifi  cant levels for all measurements. P < 0.05 was considered to be 
statistically signifi  cant.
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